Log In
Print
BCIQ
Print
Print this Print this
 

VeloThrax

  Manage Alerts
Collapse Summary General Information
Company Soligenix Inc.
DescriptionTranslocation-deficient mutant recombinant protective antigen (rPA) anthrax vaccine
Molecular Target
Mechanism of ActionVaccine
Therapeutic ModalityPreventive vaccine
Latest Stage of DevelopmentPreclinical
Standard IndicationAnthrax
Indication DetailsPrevent anthrax poisoning
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today